Obstructive lung disease medications Flashcards
Corticosteroids MOA
In mast cells: inhibit phospholipase A2 which decreases leukotriene and prostaglandin synthesis
Inhibit Th2 cells: decrease IL-4 and IL-5 which decrease mast cell and eosinophils
Inhaled corticosteroids
Beclomethasone
Budesonide
Ciclesonide
Mometasone
Fluticasone
Triamcinolone
Systemic corticosteroids
Hydrocortisone
Prednisone
Prednisolone
Methylprednisolone
Mast cell stabilizers MOA
Inhibit the release of prostaglandins and leukotrienes
Mast cell stabilizer drugs
Nedocromil
Cromolyn
Leukotriene receptor antagonists MOA
bind and block leukotriene receptors in smooth muscles
Decrease smooth muscle contraction, mucus secretion, and inflammation
Leukotriene receptor antagonists
Montekukast
Zafirlukast
both oral
Leukotriene synthesis inhibitor MOA
Inhibits 5-lipoxygenase which stops leukotriene synthesis from arachidonic acid
Effective in preventing exercise or aspirin induced asthma
Leukotriene synthesis inhibitor drugs
Zileuton
Anti-Ige Monoclonal antibody
Bind to IgE antibodies so they can’t stimulate FceR1 receptors and activate mast cells which prevents inflammatory mediator production
B2 Agonists MOA
Bind to beta2 receptors and activates adenylyl cyclase to increase cAMP production and relax smooth muscle
Can stimulate receptors on mast cells and decrease the release of inflammatory mediators
SABA drugs
Albuterol
Metaproterenol
Terbutaline
LABA drugs
Salmeterol
Formeterol
Muscarinic antagonists MOA
Bind to M3 muscarinic receptors and blocks acetylcholine leading to less smooth muscle contraction
Muscarinic antagonist drugs
Ipatropium bromide (short acting)
Tiotropium bromide (long acting)